Literature DB >> 19276177

Immune dysregulation in severe influenza.

Meredith L Heltzer1, Susan E Coffin, Kelly Maurer, Asen Bagashev, Zhe Zhang, Jordan S Orange, Kathleen E Sullivan.   

Abstract

Among previously healthy children with severe influenza, the mechanisms leading to increased pathology are not understood. We hypothesized that children with severe influenza would have high levels of circulating cytokines. To examine this, we recruited patients with severe influenza and examined plasma cytokine levels as well as the ability of peripheral blood cells to respond to stimuli. Ten patients with severe influenza were enrolled during the 2005-2007 influenza seasons. We evaluated plasma cytokine levels, circulating NK cells, and responses to TLR ligands during the illness. We compared these patients with five patients with moderate influenza, six patients with respiratory syncytial virus (RSV), and 24 noninfected controls. Patients with influenza showed depressed responses to TLR ligands when compared with RSV patients and healthy controls (P<0.05). These normalized when retested during a convalescent phase. Plasma levels of IL-6, IL-12, and IFN- were elevated in influenza patients compared with controls (P<0.05). A compromised ability to produce TNF- was reproduced by in vitro infection, and the magnitude of the effect correlated with the multiplicity of infection and induction of IFN regulatory factor 4 expression. Aberrant, systemic, innate responses to TLR ligands during influenza infection may be a consequence of specific viral attributes such as a high inoculum or rapid replication and may underlie the known susceptibility of influenza-infected patients to secondary bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276177      PMCID: PMC2698588          DOI: 10.1189/jlb.1108710

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  49 in total

1.  Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.

Authors:  SangKon Oh; J Michael McCaffery; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Authors:  H S Izurieta; W W Thompson; P Kramarz; D K Shay; R L Davis; F DeStefano; S Black; H Shinefield; K Fukuda
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

3.  Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses.

Authors:  Aleksandr S Lipatov; Samita Andreansky; Richard J Webby; Diane J Hulse; Jerold E Rehg; Scott Krauss; Daniel R Perez; Peter C Doherty; Robert G Webster; Mark Y Sangster
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

4.  Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.

Authors:  M Schmidt; A Hochhaus; S A König-Merediz; C Brendel; J Proba; G J Hoppe; B Wittig; G Ehninger; R Hehlmann; A Neubauer
Journal:  J Clin Oncol       Date:  2000-10-01       Impact factor: 44.544

5.  Protective role of beta interferon in host defense against influenza A virus.

Authors:  Iris Koerner; Georg Kochs; Ulrich Kalinke; Siegfried Weiss; Peter Staeheli
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.

Authors:  N Lee; C K Wong; P K S Chan; S W M Lun; G Lui; B Wong; D S C Hui; C W K Lam; C S Cockram; K W Choi; A C M Yeung; J W Tang; J J Y Sung
Journal:  Clin Infect Dis       Date:  2007-08-08       Impact factor: 9.079

Review 7.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Authors:  Nancy A Jewell; Negin Vaghefi; Sara E Mertz; Parvis Akter; R Stokes Peebles; Lauren O Bakaletz; Russell K Durbin; Emilio Flaño; Joan E Durbin
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Influenza-associated acute encephalopathy in Japanese children in 1994-2002.

Authors:  Takehiro Togashi; Yoshihiro Matsuzono; Mitsuo Narita; Tsuneo Morishima
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  48 in total

Review 1.  Evasion of natural killer cells by influenza virus.

Authors:  Hailong Guo; Pawan Kumar; Subramaniam Malarkannan
Journal:  J Leukoc Biol       Date:  2010-08-03       Impact factor: 4.962

Review 2.  Identifying patterns of immune-related disease: use in disease prevention and management.

Authors:  Rodney R Dietert; Judith T Zelikoff
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

3.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

4.  Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study.

Authors:  Cheng Chen; Wei Sun; Jun Chen; Jian-An Huang
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

5.  Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.

Authors:  Xiao-Xia Zhang; Qiao-Feng Wu; Yun-Liang Yan; Feng-Ling Zhang
Journal:  Inflamm Res       Date:  2017-11-24       Impact factor: 4.575

Review 6.  Evasion of innate and adaptive immune responses by influenza A virus.

Authors:  Mirco Schmolke; Adolfo García-Sastre
Journal:  Cell Microbiol       Date:  2010-05-06       Impact factor: 3.715

Review 7.  Natural killer cells: walking three paths down memory lane.

Authors:  Gundula Min-Oo; Yosuke Kamimura; Deborah W Hendricks; Tsukasa Nabekura; Lewis L Lanier
Journal:  Trends Immunol       Date:  2013-03-14       Impact factor: 16.687

8.  Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Authors:  Mark W Hall; Susan M Geyer; Chao-Yu Guo; Angela Panoskaltsis-Mortari; Philippe Jouvet; Jill Ferdinands; David K Shay; Jyotsna Nateri; Kristin Greathouse; Ryan Sullivan; Tram Tran; Shannon Keisling; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

9.  Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.

Authors:  Lisa M Kronstad; Christof Seiler; Rosemary Vergara; Susan P Holmes; Catherine A Blish
Journal:  J Immunol       Date:  2018-08-24       Impact factor: 5.422

Review 10.  Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das Clínicas of the University of São Paulo.

Authors:  Ludhmila Abrahao Hajjar; Denise Schout; Filomena Regina Barbosa Gomes Galas; David Everson Uip; Anna Sara Shafferman Levin; Helio Hehl Caiaffa Filho; Pedro Takanori Sakane; Carlos Alberto Suslik; Jose Manoel de Camargo Teixeira; Eloisa Bonfa; Antonio Alci Barone; Milton de Arruda Martins; Marcos Boulos; Jose Otavio Costa Auler
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.